Glycyrrhiza glabra (Licorice)

Chapter 96 Glycyrrhiza glabra (Licorice)




Glycyrrhiza glabra (family: Leguminosae)


Common names: licorice, glycyrrhiza






image Pharmacology


Licorice is known to exhibit many pharmacologic actions, including the following3:



The majority of these actions are discussed individually later. Although much of the pharmacology focuses on glycyrrhizin and glycyrrhetinic acid, it is worth remembering that licorice has many other components, such as flavonoids, which may have significant pharmacologic effects.



Estrogenic Activity


Most herbalists generally believe that glycyrrhiza exhibits alterative action on estrogen metabolism (i.e., when estrogen levels are too high, it inhibits estrogen action, and when estrogens are too low, it potentiates estrogen action when used in greater amounts).4 Glycyrrhetinic acid has been shown to antagonize many of the effects of estrogens, particularly exogenous estrogens.5 The estrogenic action of glycyrrhiza is due to its isoflavone content, as many isoflavone structures (e.g., daidzein and genistein from soy) are known to possess estrogenic effect. The estrogenic activity of the isoflavones appears to be more significant than the estrogen antagonism of glycyrrhetinic acid.6 Interestingly, these same components inhibit breast cancer cell growth.7



Pseudoaldosterone Activity


Long-term ingestion of glycyrrhiza in large doses leads to a well-documented pseudoaldosteronism syndrome (i.e., hypertension, hypokalemia, sodium and water retention, low plasma renin activity, and suppressed urine and serum aldosterone levels).813 In normal subjects, the amount of glycyrrhizin needed to produce these side effects is between 0.7 and 1.4 g, which corresponds to approximately 10 to 14 g of the crude herb.9 Although glycyrrhiza possesses mineralocorticoid activity (about four orders of magnitude lower than aldosterone) and binds to aldosterone receptors, it is largely without effect in adrenalectomized animals or in patients with severe adrenocorticoid insufficiency. Therefore, it can be concluded that its primary effects are largely as a result of glycyrrhetinic acid inhibiting the breakdown of aldosterone in the liver.14 Glycyrrhizin and glycyrrhetinic acid were shown to suppress 5-β-reductase, the main enzyme in humans responsible for inactivating cortisol, aldosterone, and progesterone. These effects can be put to good use in the treatment of Addison’s disease, a severe disease of adrenal insufficiency.13



Antiinflammatory and Antiallergic Activity


Glycyrrhiza has significant antiinflammatory and antiallergic activity.15,16 Although both glycyrrhizin and glycyrrhetinic acid bind to glucocorticoid receptors, and much of glycyrrhiza’s anti-inflammatory activity has been explained by its “cortisol-like effects,” many of the effects of glycyrrhiza actually antagonize or counteract cortisol.17 Antagonism to such actions of cortisol include activation of tryptophan oxygenase, accumulation of hepatic glycogen, stimulation of hepatic cholesterol synthesis, inhibition of thymus atrophy, and inhibition of adrenocorticotropic hormone synthesis and secretion. Glycyrrhizin does, however, reinforce cortisol’s inhibition of antibody formation, stress reaction, and inflammation. Like its mineralocorticoid effect, glycyrrhiza’s major influence on glucocorticoid metabolism is probably related to its suppression of 5-β-reductase activity, thus increasing the half-life of cortisol. Glycyrrhetinic acid can also increase the conversion of cortisol to the more powerful cortisone.18


Glycyrrhiza’s major cortisol-like effect relates to its ability to inhibit phospholipase A2.19 This enzyme is responsible for cleaving lipids from biomembranes for eicosanoid metabolism. In addition to this effect, glycyrrhizin was also shown to inhibit cyclic adenosine monophosphate phosphodiesterase, thereby raising cyclic adenosine monophosphate levels and prostaglandin formation by activated peritoneal macrophages from rats.20,21 Glycyrrhizin was shown to inhibit experimentally induced allergenic reactions, such as the Arthus phenomenon, the Shwartzman phenomenon, and Forssman anaphylaxis, and to be an antidote against many toxins, including diphtheria, tetanus, and tetrodotoxin.21,22


Glycyrrhizin exerts antithrombotic effects but does not potentiate the inhibitory activity of antithrombin III or heparin cofactor II toward thrombin.23



Immunostimulatory and Antiviral Effects


Glycyrrhizin and glycyrrhetinic acid were shown to induce interferon.24 The induction of interferon leads to significant antiviral activity, because interferons bind to cell surfaces, where they stimulate synthesis of intracellular proteins that block the transcription of viral DNA. The induction of interferon is also followed by activation of macrophages and augmentation of natural killer cell activity.


Glycyrrhizin was shown to directly inhibit the growth of several DNA and RNA viruses in cell cultures (vaccinia, Epstein-Barr, Herpes simplex, Newcastle disease, vesicular stomatitis viruses, severe acute respiratory syndrome [SARS]-associated coronavirus, and HIV) and to inactivate herpes simplex virus 1 (HSV-1) irreversibly.2528 Administration of glycyrrhizin to mice with herpetic encephalitis increased their survival rate on average about 2.5 times, whereas it reduced HSV-1 replication in the brain to 45.6% of the controls.29 Glycyrrhizin, as stated earlier, also inhibited the thymolytic and immunosuppressive action of cortisone. Other licorice components exerted immunomodulatory effects as well.30



Anticancer Effects


Licorice components exert a wide range of anticancer effects.31 The most active appear to be the flavonoids and coumarins. For example, isoliquiritigenin was shown to suppress colon cancer in mice via markedly decreasing both prostaglandin E2 and nitric oxide production in mouse macrophage cells.32 Isoliquiritigenin was also shown to significantly inhibit the proliferation of prostate and breast cancer cell lines in dose- and time-dependent manners.7,33 Isoliquiritigenin also significantly reduced pulmonary metastasis in mouse renal cell carcinoma and prevented the leukocytopenia caused by administration of 5-fluorouracil.34 A coumarin compound, identified as licocoumarone, was shown to be the factor in licorice that induces apoptosis.35








image Deglycyrrhizinated Licorice


Although glycyrrhetinic acid was the first drug proven to promote healing of gastric and duodenal ulcers,43 most physicians using licorice in the treatment of peptic ulcers now use DGL. DGL was actually shown to be more effective than glycyrrhetinic acid, without side effects.44


DGL’s mode of action is different than that of current drugs, such as antacids and H2-receptor antagonists, which focus on reducing gastric acidity. Although effective, these treatments can be expensive, carry some risk of toxicity, disrupt normal digestive processes, and alter the structure and function of the cells that line the digestive tract. The latter factor is just one of the reasons why peptic ulcers develop again if antacids, cimetidine, ranitidine, and similar drugs are used.


Rather than inhibit the release of acid, DGL stimulates the normal defense mechanisms that prevent ulcer formation and stimulate healing of the damaged mucous membranes. Specifically, DGL increases the following45,46:



In addition, several flavonoid components of G. glabra have shown significant activity against H. pylori, including antibiotic-resistant strains.38



Gastric Ulcers


Numerous clinical studies over the years found DGL to be an effective antiulcer compound. DGL was shown to be extremely effective in the treatment of gastric ulcers.4751 In one study, 33 gastric ulcer patients were treated with either DGL (760 mg, three times a day) or a placebo for 1 month.50 There was a significantly greater reduction in ulcer size in the DGL group (78%) than in the placebo group (34%). Complete healing occurred in 44% of those receiving DGL, but only in 6% of the placebo group.


In several head-to-head comparison studies, DGL was shown to be more effective than cimetidine (Tagamet), ranitidine (Zantac), or antacids in both short-term treatment and maintenance therapy of peptic ulcers.47,48,52 However, although these drugs are associated with significant side effects (see preceding section), DGL is extremely safe and is only a fraction of the cost.


Subsequent studies showed DGL to be as effective as Tagamet and Zantac for both short-term treatment and maintenance therapy of gastric ulcer.4749 For example, in a head-to-head comparison with Tagamet, 100 patients received either DGL (760 mg, three times a day between meals) or Tagamet (200 mg, three times a day, and 400 mg at bedtime).48 The percentage of ulcers healed after 6 and 12 weeks were similar in both groups. Although Tagamet is associated with some toxicity, DGL is extremely safe to use.


Gastric ulcers are often a result of using alcohol, aspirin, or other nonsteroidal anti-inflammatory drugs, caffeine, and other factors that decrease the integrity of the gastric lining. Because DGL was shown in human studies to reduce the gastric bleeding caused by aspirin, DGL is strongly indicated for the prevention of gastric ulcers in patients requiring long-term treatment with ulcerogenic drugs such as aspirin, nonsteroidal anti-inflammatory agents, and corticosteroids.51



Duodenal Ulcers


DGL is also effective in duodenal ulcers. This is perhaps best illustrated by one study in patients with severe duodenal ulcers: 40 patients with chronic duodenal ulcers of 4 to 12 years’ duration and more than six relapses during the previous year were treated with DGL.53 All of the patients were referred for surgery because of relentless pain, sometimes with frequent vomiting, despite treatment with bed rest, antacids, and anticholinergic drugs. Half of the patients received 3 g/day of DGL for 8 weeks; the other half received 4.5 g/day for 16 weeks. All 40 patients showed substantial improvement, usually within 5 to 7 days, and none required surgery during the 1-year follow-up. Although both dosages were effective, the higher dosage was significantly more effective than the lower dosage.


In another more recent study, the therapeutic effect of DGL was compared with that of antacids or cimetidine in 874 patients with confirmed chronic duodenal ulcers.52 Ninety-one percent of all ulcers healed within 12 weeks; there was no significant difference in healing rate in the groups. However, there were fewer relapses in the DGL group (8.2%) than in those receiving cimetidine (12.9%) or antacids (16.4%). These results, coupled with DGL’s protective effects, suggest that DGL is a superior treatment of duodenal ulcers.

Only gold members can continue reading. Log In or Register to continue

Sep 12, 2016 | Posted by in MANUAL THERAPIST | Comments Off on Glycyrrhiza glabra (Licorice)
Premium Wordpress Themes by UFO Themes